Trial Profile
To characterise the biological disease modifying antirheumatic drugs uasge pattern in patients with Rheumatoid arthritis:a multicenter,observational,real world study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 01 May 2017
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Etanercept (Primary) ; Infliximab (Primary) ; Tocilizumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Sponsors Shanghai Roche Pharmaceuticals
- 01 May 2017 New trial record